Literature DB >> 26527046

Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study.

Michihiro Satoh1, Kei Asayama2, Masahiro Kikuya2, Ryusuke Inoue2, Hirohito Metoki2, Miki Hosaka2, Megumi Tsubota-Utsugi2, Taku Obara2, Aya Ishiguro2, Keiko Murakami2, Ayako Matsuda2, Daisaku Yasui2, Takahisa Murakami2, Nariyasu Mano2, Yutaka Imai2, Takayoshi Ohkubo2.   

Abstract

The prognostic significance of white-coat hypertension (WCHT) is controversial, and different findings on self-measured home measurements and 24-h ambulatory monitoring make identifying WCHT difficult. We examined whether individuals with partially or completely defined WCHT, as well as masked hypertension, as determined by different out-of-office blood pressure measurements, have a distinct long-term stroke risk. We followed 1464 participants (31.8% men; mean age, 60.6±10.8 years) in the general population of Ohasama, Japan, for a median of 17.1 years. A first stroke occurred in 212 subjects. Using sustained normal blood pressure (events/n=61/776) as a reference, adjusted hazard ratios for stroke (95% confidence intervals; events/n) were 1.38 (0.82-2.32; 19/137) for complete WCHT (isolated office hypertension), 2.16 (1.36-3.43; 29/117) for partial WCHT (either home or ambulatory normotension with office hypertension), 2.05 (1.24-3.41; 23/100) for complete masked hypertension (both home and ambulatory hypertension with office normotension), 2.08 (1.37-3.16; 38/180) for partial masked hypertension (either home or ambulatory hypertension with office normotension), and 2.46 (1.61-3.77; 42/154) for sustained hypertension. When partial WCHT and partial masked hypertension groups were further divided into participants only with home hypertension and those only with ambulatory hypertension, all subgroups had a significantly higher stroke risk (adjusted hazard ratio ≥1.84, P≤0.04). In conclusion, impacts of partial WCHT as well as partial masked hypertension for long-term stroke risk were comparable to those of complete masked hypertension or sustained hypertension. We need both home and 24-h ambulatory blood pressure measurements to evaluate stroke risk accurately.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; epidemiology; hypertension; population; stroke

Mesh:

Year:  2015        PMID: 26527046     DOI: 10.1161/HYPERTENSIONAHA.115.06461

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

1.  Prognostic Value of Masked Uncontrolled Hypertension.

Authors:  Sante D Pierdomenico; Anna M Pierdomenico; Francesca Coccina; Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Iddo Z Ben-Dov; Wanpen Vongpatanasin; José R Banegas; Luis M Ruilope; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

Review 2.  A personal history of research on hypertension From an encounter with hypertension to the development of hypertension practice based on out-of-clinic blood pressure measurements.

Authors:  Yutaka Imai
Journal:  Hypertens Res       Date:  2022-09-08       Impact factor: 5.528

Review 3.  An Update on Masked Hypertension.

Authors:  D Edmund Anstey; Daniel Pugliese; Marwah Abdalla; Natalie A Bello; Raymond Givens; Daichi Shimbo
Journal:  Curr Hypertens Rep       Date:  2017-10-25       Impact factor: 5.369

Review 4.  Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Apichard Sukonthasarn; Yuda Turana; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yu-Qing Zhang; Sungha Park; Huynh Van Minh; Naoko Tomitani; Tomoyuki Kabutoya; Narsingh Verma; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-26       Impact factor: 3.738

5.  Left ventricular hypertrophy in isolated and dual masked hypertension.

Authors:  Cesare Cuspidi; Rita Facchetti; Fosca Quarti-Trevano; Raffaella Dell'Oro; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

6.  Home blood pressure monitoring in the 21st century.

Authors:  George S Stergiou; Kazuomi Kario; Anastasios Kollias; Richard J McManus; Takayoshi Ohkubo; Gianfranco Parati; Yutaka Imai
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07       Impact factor: 3.738

7.  White-Coat Hypertension: A True Cardiovascular Risk?: Commentary on "The impact of white-coat hypertension on cardiac mechanics".

Authors:  Arya Mani
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-21       Impact factor: 3.738

8.  Prevalence and clinical outcomes of white-coat and masked hypertension: Analysis of a large ambulatory blood pressure database.

Authors:  Giuliano Tocci; Vivianne Presta; Ilaria Figliuzzi; Nadia Attalla El Halabieh; Allegra Battistoni; Roberta Coluccia; Michela D'Agostino; Andrea Ferrucci; Massimo Volpe
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-25       Impact factor: 3.738

9.  Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both?

Authors:  D Edmund Anstey; Paul Muntner; Natalie A Bello; Daniel N Pugliese; Yuichiro Yano; Ian M Kronish; Kristi Reynolds; Joseph E Schwartz; Daichi Shimbo
Journal:  Hypertension       Date:  2018-11       Impact factor: 9.897

10.  Is Persistent Office Hypertension in Treated Hypertensive Patients a Benign Condition?

Authors:  Gabriel Coll-de-Tuero; Susanna Vargas-Vila; Pere Torguet
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-09-28       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.